Skip to main content

Impact analysis: Enacted Medicare cuts

DataGen has completed its analysis of enacted Medicare cuts, the results of which are shared here. Please note that this analysis is intended for advocacy purposes only and should be used as an indication of the extent to which hospital providers nationwide have been impacted by existing Medicare provider payment cuts.

These cuts were enacted by Congress to achieve Medicare payment policy and long-term deficit reduction goals. This DataGen impact analysis includes major cuts enacted since 2010.

The enacted legislative cuts analyzed consist of:

  • Medicare marketbasket, Medicare Disproportionate Share Hospital and quality adjustments authorized by the Affordable Care Act of 2010; note that for the purposes of this analysis, quality adjustments are broken out into their own category;
  • the effect of the 2.0% across-the-board sequestration reduction to payments authorized by the Budget Control Act of 2011;
  • inpatient coding adjustment reductions authorized by the American Taxpayer Relief Act of 2012;
  • the reduction in bad debt payments authorized by the Middle Class Tax Relief and Job Creation Act of 2012;
  • payment adjustments for services paid for under the clinical laboratory fee schedule authorized by the Protecting Access to Medicare Act of 2014;
  • reduction of OPPS payments to non-excepted off-campus sites to a level equivalent to that paid under the Medicare Physician Fee Schedule required by the Bipartisan Budget Act of 2015;
  • marketbasket adjustments authorized by the Medicare Access and CHIP Reauthorization Act of 2015;
  • change in Home Health Prospective Payment System payments resulting from the implementation of the Patient-Driven Grouping Model; and
  • payment reductions authorized by the Bipartisan Budget Act of 2018, including adding hospice to the Inpatient PPS short-stay post-acute care transfer policy.
The enacted regulatory cuts analyzed consist of:
  • regulatory coding adjustments implemented by CMS;
  • 2.0% reduction to the calendar year 2016 outpatient marketbasket update for rate inflation due to packaging of laboratory payments;
  • long-term care hospital site-neutral payment adjustment implemented in the federal fiscal year 2016 final rule;
  • net payment impacts resulting from CMS’ reduction in OPPS payments for 340B Program purchased drugs;
  • reduction in payments for Wholesale Acquisition Cost-based drugs from WAC+6% to WAC+3%;
  • change in Skilled Nursing Facility PPS payment methodology from the Resource Utilization Group-IV system to the Patient-Driven Payment Model; and
  • reduction of OPPS payments for clinic services provided at excepted off-campus sites to a level equivalent to that paid under the Medicare Physician Fee Schedule.

The quality cuts analyzed include estimated impacts from Medicare’s Value-based Purchasing, Readmissions Reduction and Hospital-acquired Conditions programs.

These cuts could have a major impact on hospital finances and operations in the coming years. To learn more about this impact and about how to thrive in alternative payment models, contact us today.

Popular posts from this blog

The Future of Healthcare: Top Trends Providers Need to Address Now

As we emerge from a global pandemic, accountable care organizations must address key new trends now to maintain progress toward value-based care and mitigate financial risk.  Analytics are key to helping ACOs gain a better understanding of trends so they can identify opportunities to drive quality improvement. These trends include: gaps in access to clinical care;  shifts in patient volume; increased demand for virtual care; and  social determinants of health challenges.  To better understand rising trends and actions providers should take, we will reach out to hospital and health system leaders to discuss how recent trends influenced their decision to adopt value-based contracts. Then, during our July 28 webinar, we will release a comprehensive market report on these trends and implications for the future. Preventing gaps in access to clinical care Advanced payment models incentivize ACOs to deliver high-quality care and close gaps in care for patients, thereby earning shared savings

ACOs must act now to get ahead of MSSP changes

Redesigned MSSP program The Medicare Shared Savings Program, one of Medicare’s largest alternative payment models, allows providers and suppliers the opportunity to form an Accountable Care Organization. It was redesigned in 2018, establishing “Pathways to Success” as a way to restructure participation and encourage ACOs to transition to two-sided risk models.  As part of this rule, a BASIC track was established for ACOs to begin participation under an upside-only risk model and to incrementally phase into a two-sided risk model through a glide path. The glide path is composed of Levels A through E, in which there is progressively greater financial risk and potential opportunity for savings.  It is critically important for ACOs to understand how their level of participation in MSSP will change in the coming years. COVID-19 impact on MSSP advancement The COVID-19 public health emergency has disrupted efforts to improve population health and care coordination, and has resulted in a lack

Three more years of CJR: What participating hospitals need to know

On April 29, CMS issued a final rule to extend the Comprehensive Care for Joint Replacement model by an additional three performance years. A number of modifications effective in the extension period aim to improve the model and reflect Medicare policy changes over the last several years. CMS anticipates that CJR will save the Medicare program an additional $217 million over the extension period. The following summarizes the most notable model changes: Three new performance years have been added: PY 6 will include episodes that end between Oct. 1, 2021 and Dec. 31, 2022; PY 7 will include episodes that end between Jan. 1, 2023 and Dec. 31, 2023; and PY 8 will include episodes that end between Jan. 1, 2024 and Dec. 31, 2024. Episode definitions under the model have been expanded to include total hip arthroplasty and total knee arthroplasty procedures performed in the hospital outpatient setting. The episode categories under the extension are site-neutral and are defined as: MS-DRG 470: